ReP USP - Resultado da busca

Artigo de periodico
Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy (2021)
Mori, Augusto Akira ; Castro, Lara Reinel de; Bortolin, Raul Hernandes ; Bastos, Gisele Medeiros; Oliveira, Victor Fernandes de ; Ferreira, Glaucio Monteiro ; Hirata, Thiago Dominguez Crespo ; Fajardo, Cristina Moreno ; Sampaio, Marcelo Ferraz; Moreira, Dalmo Antonio Ribeiro ; Mateos, José Carlos Pachon; Correia, Edileide de Barros; Sousa, Amanda Guerra de Moraes Rego ; Brion, Maria ; Carracedo, Angel ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Forensic Science International. Unidades: FCF, IDPC
Subjects: MORTE SÚBITA, HIPERTROFIA VENTRICULAR ESQUERDA, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORI, Augusto Akira et al. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy. Forensic Science International, v. 52, p. 1-10 art. 102478, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.fsigen.2021.102478. Acesso em: 01 nov. 2024.
APA
Mori, A. A., Castro, L. R. de, Bortolin, R. H., Bastos, G. M., Oliveira, V. F. de, Ferreira, G. M., et al. (2021). Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy. Forensic Science International, 52, 1-10 art. 102478. doi:10.1016/j.fsigen.2021.102478
NLM
Mori AA, Castro LR de, Bortolin RH, Bastos GM, Oliveira VF de, Ferreira GM, Hirata TDC, Fajardo CM, Sampaio MF, Moreira DAR, Mateos JCP, Correia E de B, Sousa AG de MR, Brion M, Carracedo A, Hirata RDC, Hirata MH. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy [Internet]. Forensic Science International. 2021 ; 52 1-10 art. 102478.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.fsigen.2021.102478
Vancouver
Mori AA, Castro LR de, Bortolin RH, Bastos GM, Oliveira VF de, Ferreira GM, Hirata TDC, Fajardo CM, Sampaio MF, Moreira DAR, Mateos JCP, Correia E de B, Sousa AG de MR, Brion M, Carracedo A, Hirata RDC, Hirata MH. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy [Internet]. Forensic Science International. 2021 ; 52 1-10 art. 102478.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.fsigen.2021.102478
Artigo de periodico
Isohemigossypolone: antiophidic properties of a naphthoquinone isolated from Pachira aquatica Aubl (2021)
Vieira, Sâmela Alves Pereira Batista; Santos, Benedito Matheus dos ; Santos Júnior, Célio Dias ; Paula, Vanderlucia Fonseca de; Gomes, Mário Sérgio Rocha; Ferreira, Glaucio Monteiro ; Gonçalves, Ricardo Lemes; Hirata, Mario Hiroyuki ; Silva, Roosevelt Alves da ; Brandeburgo, Maria Inês Homsi; Mendes, Mirian Machado
Source: Comparative Biochemistry and Physiology C. Unidade: FCF
Subjects: VENENOS DE ORIGEM ANIMAL, COBRAS, FOSFOLIPASES A, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Sâmela Alves Pereira Batista et al. Isohemigossypolone: antiophidic properties of a naphthoquinone isolated from Pachira aquatica Aubl. Comparative Biochemistry and Physiology C, v. 245, p. 1-11 art. 109028, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.cbpc.2021.109028. Acesso em: 01 nov. 2024.
APA
Vieira, S. A. P. B., Santos, B. M. dos, Santos Júnior, C. D., Paula, V. F. de, Gomes, M. S. R., Ferreira, G. M., et al. (2021). Isohemigossypolone: antiophidic properties of a naphthoquinone isolated from Pachira aquatica Aubl. Comparative Biochemistry and Physiology C, 245, 1-11 art. 109028. doi:10.1016/j.cbpc.2021.109028
NLM
Vieira SAPB, Santos BM dos, Santos Júnior CD, Paula VF de, Gomes MSR, Ferreira GM, Gonçalves RL, Hirata MH, Silva RA da, Brandeburgo MIH, Mendes MM. Isohemigossypolone: antiophidic properties of a naphthoquinone isolated from Pachira aquatica Aubl [Internet]. Comparative Biochemistry and Physiology C. 2021 ; 245 1-11 art. 109028.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.cbpc.2021.109028
Vancouver
Vieira SAPB, Santos BM dos, Santos Júnior CD, Paula VF de, Gomes MSR, Ferreira GM, Gonçalves RL, Hirata MH, Silva RA da, Brandeburgo MIH, Mendes MM. Isohemigossypolone: antiophidic properties of a naphthoquinone isolated from Pachira aquatica Aubl [Internet]. Comparative Biochemistry and Physiology C. 2021 ; 245 1-11 art. 109028.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.cbpc.2021.109028
Artigo de periodico
Antiophidic activity of the secondary metabolite lupeol isolated from Zanthoxylum monogynum (2021)
Santos, Benedito Matheus dos ; Ferreira, Glaucio Monteiro ; Tavares, Maurício Temotheo ; Bona, Júlio César De ; Hirata, Mario Hiroyuki ; Paula, Vanderlúcia Fonseca de; Saturnino, Klaus Casaro ; Soares, Andreimar Martins ; Mendes, Mirian Machado
Source: Toxicon. Unidade: FCF
Subjects: VENENOS DE ORIGEM ANIMAL, ANTÍDOTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Benedito Matheus dos et al. Antiophidic activity of the secondary metabolite lupeol isolated from Zanthoxylum monogynum. Toxicon, v. 193, p. 38–47, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.toxicon.2021.01.018. Acesso em: 01 nov. 2024.
APA
Santos, B. M. dos, Ferreira, G. M., Tavares, M. T., Bona, J. C. D., Hirata, M. H., Paula, V. F. de, et al. (2021). Antiophidic activity of the secondary metabolite lupeol isolated from Zanthoxylum monogynum. Toxicon, 193, 38–47. doi:10.1016/j.toxicon.2021.01.018
NLM
Santos BM dos, Ferreira GM, Tavares MT, Bona JCD, Hirata MH, Paula VF de, Saturnino KC, Soares AM, Mendes MM. Antiophidic activity of the secondary metabolite lupeol isolated from Zanthoxylum monogynum [Internet]. Toxicon. 2021 ; 193 38–47.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.toxicon.2021.01.018
Vancouver
Santos BM dos, Ferreira GM, Tavares MT, Bona JCD, Hirata MH, Paula VF de, Saturnino KC, Soares AM, Mendes MM. Antiophidic activity of the secondary metabolite lupeol isolated from Zanthoxylum monogynum [Internet]. Toxicon. 2021 ; 193 38–47.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.toxicon.2021.01.018
Artigo de periodico
Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol (2021)
Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Ferreira, Glaucio Monteiro ; Los, Bruna; Barbosa, Thais Kristini Almendros Afonso; Marçal, Elisangela da Silva Rodrigues; Hernandez, Carolina Dagli; Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Mori, Augusto Akira ; Hirata, Thiago Dominguez Crespo ; Nakaya, Helder Takashi Imoto ; Bastos, Gisele Medeiros ; Thurow, Helena Strelow ; Gonçalves, Rodrigo Marques; Araújo, Daniel Branco de; Zatz, Henry Paulo; Bertolami, Adriana; Faludi, André Arpad; Bertolami, Marcelo Chiara ; Sousa, Amanda Guerra de Moraes Rego ; França, Joao Italo Dias ; Jannes, Cinthia Elim; Pereira, Alexandre da Costa; Nakazone, Marcelo Arruda; Souza, Dorotéia Rossi Silva; Carmo, Tayanne Silva; Sampaio, Marcelo Ferraz; Gorjão, Renata ; Curi, Tania Cristina Pithon ; Moriel, Patricia; Silbiger, Vivian Nogueira ; Luchessi, André Ducati ; Araújo, Jéssica Nayara Góes de; Naslavsky, Michel ; Wang, Jaqueline Yu Ting; Kronenberger, Thales ; Cerda, Alvaro ; Wang, Hui Tzu Lin; Garofalo, Adriana Regina; Fajardo, Cristina Moreno ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Research in Social and Administrative Pharmacy. Unidades: FCF, IDPC, FM, IB
Subjects: GENÔMICA, HIPERCOLESTEROLEMIA, FARMACOGENÉTICA, EXONS, LINFÓCITOS, LINHAGEM CELULAR, MUTAGÊNESE, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Jéssica Bassani et al. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, v. 17, n. 7, p. 1347-1355, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.sapharm.2020.10.007. Acesso em: 01 nov. 2024.
APA
Borges, J. B., Oliveira, V. F. de, Ferreira, G. M., Los, B., Barbosa, T. K. A. A., Marçal, E. da S. R., et al. (2021). Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, 17( 7), 1347-1355. doi:10.1016/j.sapharm.2020.10.007
NLM
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Vancouver
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Artigo de periodico
Harmful effects of granulocytic myeloid-derived suppressor cells on tuberculosis caused by hypervirulent mycobacteria (2021)
Bomfim, Caio César Barbosa ; Amaral, Eduardo Pinheiro ; Carvalho, Igor Santiago ; Santos, Gislane Almeida ; Salles, Érika Machado de ; Hastreiter, Araceli Aparecida ; Nascimento, Rogério Silva do; Almeida, Fabricio M.; Simão, Thatiana Lopes Biá Ventura ; Rezende, Andreza Linhares; Hirata, Mario Hiroyuki ; Fock, Ricardo Ambrósio ; Alvarez, José Maria ; Lasunskaia, Elena B ; Lima, Maria Regina D'Império
Source: Journal of Infectious Diseases. Unidades: ICB, FCF
Subjects: TUBERCULOSE PULMONAR, CÉLULAS SANGUINEAS, GRANULOCITOS CITOPLASMATICOS, MEDULA ÓSSEA DE ANIMAL, VIRULÊNCIA, NEUTRÓFILOS, PROLIFERAÇÃO CELULAR, MYCOBACTERIUM BOVIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOMFIM, Caio César Barbosa et al. Harmful effects of granulocytic myeloid-derived suppressor cells on tuberculosis caused by hypervirulent mycobacteria. Journal of Infectious Diseases, v. 223, n. 3, p. 494–507, 2021Tradução . . Disponível em: https://doi.org/10.1093/infdis/jiaa708. Acesso em: 01 nov. 2024.
APA
Bomfim, C. C. B., Amaral, E. P., Carvalho, I. S., Santos, G. A., Salles, É. M. de, Hastreiter, A. A., et al. (2021). Harmful effects of granulocytic myeloid-derived suppressor cells on tuberculosis caused by hypervirulent mycobacteria. Journal of Infectious Diseases, 223( 3), 494–507. doi:10.1093/infdis/jiaa708
NLM
Bomfim CCB, Amaral EP, Carvalho IS, Santos GA, Salles ÉM de, Hastreiter AA, Nascimento RS do, Almeida FM, Simão TLBV, Rezende AL, Hirata MH, Fock RA, Alvarez JM, Lasunskaia EB, Lima MRD'I. Harmful effects of granulocytic myeloid-derived suppressor cells on tuberculosis caused by hypervirulent mycobacteria [Internet]. Journal of Infectious Diseases. 2021 ; 223( 3): 494–507.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1093/infdis/jiaa708
Vancouver
Bomfim CCB, Amaral EP, Carvalho IS, Santos GA, Salles ÉM de, Hastreiter AA, Nascimento RS do, Almeida FM, Simão TLBV, Rezende AL, Hirata MH, Fock RA, Alvarez JM, Lasunskaia EB, Lima MRD'I. Harmful effects of granulocytic myeloid-derived suppressor cells on tuberculosis caused by hypervirulent mycobacteria [Internet]. Journal of Infectious Diseases. 2021 ; 223( 3): 494–507.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1093/infdis/jiaa708
Artigo de periodico
CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy (2020)
Genvigir, Fabiana Dalla Vecchia; Campos-Salazar, Antony Brayan ; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Doi, Sonia de Quateli; Cerda, Alvaro; Hirata, Mario Hiroyuki ; Herrero, María José; Hirata, Rosario Dominguez Crespo
Source: Pharmacogenomics. Unidade: FCF
Subjects: TRANSPLANTE DE RIM, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy. Pharmacogenomics, v. 21, n. 1, p. 7-21, 2020Tradução . . Disponível em: https://doi.org/10.2217/pgs-2019-0120. Acesso em: 01 nov. 2024.
APA
Genvigir, F. D. V., Campos-Salazar, A. B., Felipe, C. R., Silva Junior, H. T., Pestana, J. O. M., Doi, S. de Q., et al. (2020). CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy. Pharmacogenomics, 21( 1), 7-21. doi:10.2217/pgs-2019-0120
NLM
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Pestana JOM, Doi S de Q, Cerda A, Hirata MH, Herrero MJ, Hirata RDC. CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy [Internet]. Pharmacogenomics. 2020 ; 21( 1): 7-21.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2217/pgs-2019-0120
Vancouver
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Pestana JOM, Doi S de Q, Cerda A, Hirata MH, Herrero MJ, Hirata RDC. CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy [Internet]. Pharmacogenomics. 2020 ; 21( 1): 7-21.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2217/pgs-2019-0120
Artigo de periodico
High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection (2020)
Alves, Matheus Silva; Cariolano, Marilha da Silva; Ferreira, Hivylla Lorrana dos Santos; Silva, Elen Sousa de Abreu; Felipe, Karen Karollynny Pereira; Monteiro, Silvio Gomes; Sousa, Eduardo Martins de; Abreu, Afonso Gomes; Campbell, Lee Ann; Rosenfeld, Michael E; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Bastos, Gisele Medeiros ; Silva, Ilana Cristina de Paula Abreu; Lima Neto, Lidio Gonçalves
Source: Brazilian Journal of Microbiology. Unidade: FCF
Subjects: INFECÇÕES RESPIRATÓRIAS, CHLAMYDIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Matheus Silva et al. High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection. Brazilian Journal of Microbiology, v. 51, p. 629–636, 2020Tradução . . Disponível em: https://doi.org/10.1007/s42770-020-00229-w. Acesso em: 01 nov. 2024.
APA
Alves, M. S., Cariolano, M. da S., Ferreira, H. L. dos S., Silva, E. S. de A., Felipe, K. K. P., Monteiro, S. G., et al. (2020). High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection. Brazilian Journal of Microbiology, 51, 629–636. doi:10.1007/s42770-020-00229-w
NLM
Alves MS, Cariolano M da S, Ferreira HL dos S, Silva ES de A, Felipe KKP, Monteiro SG, Sousa EM de, Abreu AG, Campbell LA, Rosenfeld ME, Hirata MH, Hirata RDC, Bastos GM, Silva IC de PA, Lima Neto LG. High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection [Internet]. Brazilian Journal of Microbiology. 2020 ; 51 629–636.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s42770-020-00229-w
Vancouver
Alves MS, Cariolano M da S, Ferreira HL dos S, Silva ES de A, Felipe KKP, Monteiro SG, Sousa EM de, Abreu AG, Campbell LA, Rosenfeld ME, Hirata MH, Hirata RDC, Bastos GM, Silva IC de PA, Lima Neto LG. High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection [Internet]. Brazilian Journal of Microbiology. 2020 ; 51 629–636.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s42770-020-00229-w
Artigo de periodico
Corrigendum: polymorphisms in genes affecting interferon-γ production and Th1 T cell differentiation are associated with progression to Chagas disease cardiomyopathy (2020)
Barros, Amanda Farage Frade; Ianni, Bárbara Maria; Cabantous, Sandrine; Pissetti, Cristina Wide; Saba, Bruno; Wang, Hui Tzu Lin; Buck, Paula; Marin Neto, José Antonio; Schmidt, André; Dias, Fabrício; Hirata, Mario Hiroyuki ; Sampaio, Marcelo; Fragata, Abílio; Pereira, Alexandre Costa; Donadi, Eduardo Antônio; Rodrigues, Virmondes; Kalil Filho, Jorge Elias ; Chevillard, Christophe; Cunha Neto, Edecio
Source: Frontiers in Immunology. Unidades: FM, FMRP, FCF
Subjects: DOENÇA DE CHAGAS, POLIMORFISMO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARROS, Amanda Farage Frade et al. Corrigendum: polymorphisms in genes affecting interferon-γ production and Th1 T cell differentiation are associated with progression to Chagas disease cardiomyopathy. Frontiers in Immunology, v. 11, 2020Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2020.593759. Acesso em: 01 nov. 2024.
APA
Barros, A. F. F., Ianni, B. M., Cabantous, S., Pissetti, C. W., Saba, B., Wang, H. T. L., et al. (2020). Corrigendum: polymorphisms in genes affecting interferon-γ production and Th1 T cell differentiation are associated with progression to Chagas disease cardiomyopathy. Frontiers in Immunology, 11. doi:10.3389/fimmu.2020.593759
NLM
Barros AFF, Ianni BM, Cabantous S, Pissetti CW, Saba B, Wang HTL, Buck P, Marin Neto JA, Schmidt A, Dias F, Hirata MH, Sampaio M, Fragata A, Pereira AC, Donadi EA, Rodrigues V, Kalil Filho JE, Chevillard C, Cunha Neto E. Corrigendum: polymorphisms in genes affecting interferon-γ production and Th1 T cell differentiation are associated with progression to Chagas disease cardiomyopathy [Internet]. Frontiers in Immunology. 2020 ; 11[citado 2024 nov. 01 ] Available from: https://doi.org/10.3389/fimmu.2020.593759
Vancouver
Barros AFF, Ianni BM, Cabantous S, Pissetti CW, Saba B, Wang HTL, Buck P, Marin Neto JA, Schmidt A, Dias F, Hirata MH, Sampaio M, Fragata A, Pereira AC, Donadi EA, Rodrigues V, Kalil Filho JE, Chevillard C, Cunha Neto E. Corrigendum: polymorphisms in genes affecting interferon-γ production and Th1 T cell differentiation are associated with progression to Chagas disease cardiomyopathy [Internet]. Frontiers in Immunology. 2020 ; 11[citado 2024 nov. 01 ] Available from: https://doi.org/10.3389/fimmu.2020.593759
Artigo de periodico
Characterization of the adipogenic protein E4orf1 from adenovirus 36 through an in silico approach (2020)
Gutiérrez, Alvaro; Ferreira, Glaucio Monteiro ; Machuca, Juan; Venthur, Herbert; Feres, Fausto; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Cerda, Alvaro
Source: Journal of Molecular Modeling. Unidade: FCF
Subjects: ADENOVÍRUS, OBESIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUTIÉRREZ, Alvaro et al. Characterization of the adipogenic protein E4orf1 from adenovirus 36 through an in silico approach. Journal of Molecular Modeling, v. 26, p. 1-9 art. 285, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00894-020-04531-0. Acesso em: 01 nov. 2024.
APA
Gutiérrez, A., Ferreira, G. M., Machuca, J., Venthur, H., Feres, F., Hirata, M. H., et al. (2020). Characterization of the adipogenic protein E4orf1 from adenovirus 36 through an in silico approach. Journal of Molecular Modeling, 26, 1-9 art. 285. doi:10.1007/s00894-020-04531-0
NLM
Gutiérrez A, Ferreira GM, Machuca J, Venthur H, Feres F, Hirata MH, Hirata RDC, Cerda A. Characterization of the adipogenic protein E4orf1 from adenovirus 36 through an in silico approach [Internet]. Journal of Molecular Modeling. 2020 ; 26 1-9 art. 285.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00894-020-04531-0
Vancouver
Gutiérrez A, Ferreira GM, Machuca J, Venthur H, Feres F, Hirata MH, Hirata RDC, Cerda A. Characterization of the adipogenic protein E4orf1 from adenovirus 36 through an in silico approach [Internet]. Journal of Molecular Modeling. 2020 ; 26 1-9 art. 285.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00894-020-04531-0
Trabalho de evento-resumo
Polimorfismos en CYP3A5, CYP3A4 y por influyen en la respuesta terapéutica al tacrolimus y everolimus en receptores de trasplante renal (2019)
Genvigir, Fabiana Dalla Vecchia; Campos-Salazar, Antony Brayan ; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Medina-Pestana, José Osmar ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Libro de Abstracts. Conference titles: Congreso Interdisciplinar en Genética Humana. Unidade: FCF
Subjects: POLIMORFISMO, BIOTRANSFORMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. Polimorfismos en CYP3A5, CYP3A4 y por influyen en la respuesta terapéutica al tacrolimus y everolimus en receptores de trasplante renal. 2019, Anais.. Madrid: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, 2019. . Acesso em: 01 nov. 2024.
APA
Genvigir, F. D. V., Campos-Salazar, A. B., Felipe, C. R., Silva Junior, H. T., Medina-Pestana, J. O., Hirata, M. H., & Hirata, R. D. C. (2019). Polimorfismos en CYP3A5, CYP3A4 y por influyen en la respuesta terapéutica al tacrolimus y everolimus en receptores de trasplante renal. In Libro de Abstracts. Madrid: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Medina-Pestana JO, Hirata MH, Hirata RDC. Polimorfismos en CYP3A5, CYP3A4 y por influyen en la respuesta terapéutica al tacrolimus y everolimus en receptores de trasplante renal. Libro de Abstracts. 2019 ;[citado 2024 nov. 01 ]
Vancouver
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Medina-Pestana JO, Hirata MH, Hirata RDC. Polimorfismos en CYP3A5, CYP3A4 y por influyen en la respuesta terapéutica al tacrolimus y everolimus en receptores de trasplante renal. Libro de Abstracts. 2019 ;[citado 2024 nov. 01 ]
Dissertação (Mestrado)
Caracterização funcional in vitro de variantes no gene PCSK9 identificadas em pacientes com Hipercolesterolemia Familial (2019)
Los, Bruna; Hirata, Mario Hiroyuki (Orientador)
Unidade: FCF
Subjects: HIPERCOLESTEROLEMIA, LIPOPROTEÍNAS LDL, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna. Caracterização funcional in vitro de variantes no gene PCSK9 identificadas em pacientes com Hipercolesterolemia Familial. 2019. Dissertação (Mestrado) – Universidade de São Paulo, São Paulo, 2019. Disponível em: http://www.teses.usp.br/teses/disponiveis/9/9136/tde-02072019-175026/. Acesso em: 01 nov. 2024.
APA
Los, B. (2019). Caracterização funcional in vitro de variantes no gene PCSK9 identificadas em pacientes com Hipercolesterolemia Familial (Dissertação (Mestrado). Universidade de São Paulo, São Paulo. Recuperado de http://www.teses.usp.br/teses/disponiveis/9/9136/tde-02072019-175026/
NLM
Los B. Caracterização funcional in vitro de variantes no gene PCSK9 identificadas em pacientes com Hipercolesterolemia Familial [Internet]. 2019 ;[citado 2024 nov. 01 ] Available from: http://www.teses.usp.br/teses/disponiveis/9/9136/tde-02072019-175026/
Vancouver
Los B. Caracterização funcional in vitro de variantes no gene PCSK9 identificadas em pacientes com Hipercolesterolemia Familial [Internet]. 2019 ;[citado 2024 nov. 01 ] Available from: http://www.teses.usp.br/teses/disponiveis/9/9136/tde-02072019-175026/
Trabalho de evento-resumo periodico
CYP3A5 and ABCB1 polymorphisms influence tracrolimus exposure in Brazilian and Spanish kidney transplant recipients (2019)
Genvigir, Fabiana Dalla Vecchia; Campos-Salazar, Antony Brayan ; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Hirata, Mario Hiroyuki ; Oliveira, Gladys; Herrero, María José; Pellicer, Salvador Francisco Aliño; Hirata, Rosario Dominguez Crespo
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Congress of São Paulo. Unidade: FCF
Subjects: POLIMORFISMO, BIOTRANSFORMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. CYP3A5 and ABCB1 polymorphisms influence tracrolimus exposure in Brazilian and Spanish kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf. Acesso em: 01 nov. 2024. , 2019
APA
Genvigir, F. D. V., Campos-Salazar, A. B., Felipe, C. R., Silva Junior, H. T., Pestana, J. O. M., Hirata, M. H., et al. (2019). CYP3A5 and ABCB1 polymorphisms influence tracrolimus exposure in Brazilian and Spanish kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
NLM
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Pestana JOM, Hirata MH, Oliveira G, Herrero MJ, Pellicer SFA, Hirata RDC. CYP3A5 and ABCB1 polymorphisms influence tracrolimus exposure in Brazilian and Spanish kidney transplant recipients [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 39 res. CFSP078.[citado 2024 nov. 01 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Vancouver
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Pestana JOM, Hirata MH, Oliveira G, Herrero MJ, Pellicer SFA, Hirata RDC. CYP3A5 and ABCB1 polymorphisms influence tracrolimus exposure in Brazilian and Spanish kidney transplant recipients [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 39 res. CFSP078.[citado 2024 nov. 01 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Trabalho de evento-resumo periodico
Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients (2019)
Bortolin, Raul Hernandes ; Freitas, Renata Caroline Costa de ; Genvigir, Fabiana Dalla Vecchia; Bonezi, Vivian; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Cerda, Alvaro; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Congress of São Paulo. Unidade: FCF
Subjects: EXPRESSÃO GÊNICA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORTOLIN, Raul Hernandes et al. Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf. Acesso em: 01 nov. 2024. , 2019
APA
Bortolin, R. H., Freitas, R. C. C. de, Genvigir, F. D. V., Bonezi, V., Felipe, C. R., Silva Junior, H. T., et al. (2019). Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
NLM
Bortolin RH, Freitas RCC de, Genvigir FDV, Bonezi V, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Hirata MH, Hirata RDC. Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 186 res. CFSP372.[citado 2024 nov. 01 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Vancouver
Bortolin RH, Freitas RCC de, Genvigir FDV, Bonezi V, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Hirata MH, Hirata RDC. Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 186 res. CFSP372.[citado 2024 nov. 01 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Artigo de periodico
Genetic susceptibility in pharmacodynamic and pharmacokinetic pathways underlying drug-induced arrhythmia and sudden unexplained deaths (2019)
Matilla, Marina Martinez; Verea, Alejandro J. Blanco; Santori, Montserrat; Bermejo, Juan Ansede; Luis, Eva Ramos; Gil, Rocio; Bermejo, Ana María; Lotufo Neto, Francisco; Hirata, Mario Hiroyuki ; Brisighelli, Francesca; Páramo, Mario; Carracedo, Ángel M; Brion, Maria
Source: Forensic Science International. Unidades: FM, FCF
Subjects: FARMACOCINÉTICA, FARMACODINÂMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATILLA, Marina Martinez et al. Genetic susceptibility in pharmacodynamic and pharmacokinetic pathways underlying drug-induced arrhythmia and sudden unexplained deaths. Forensic Science International, v. 42, p. 203-212, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.fsigen.2019.07.010. Acesso em: 01 nov. 2024.
APA
Matilla, M. M., Verea, A. J. B., Santori, M., Bermejo, J. A., Luis, E. R., Gil, R., et al. (2019). Genetic susceptibility in pharmacodynamic and pharmacokinetic pathways underlying drug-induced arrhythmia and sudden unexplained deaths. Forensic Science International, 42, 203-212. doi:10.1016/j.fsigen.2019.07.010
NLM
Matilla MM, Verea AJB, Santori M, Bermejo JA, Luis ER, Gil R, Bermejo AM, Lotufo Neto F, Hirata MH, Brisighelli F, Páramo M, Carracedo ÁM, Brion M. Genetic susceptibility in pharmacodynamic and pharmacokinetic pathways underlying drug-induced arrhythmia and sudden unexplained deaths [Internet]. Forensic Science International. 2019 ; 42 203-212.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.fsigen.2019.07.010
Vancouver
Matilla MM, Verea AJB, Santori M, Bermejo JA, Luis ER, Gil R, Bermejo AM, Lotufo Neto F, Hirata MH, Brisighelli F, Páramo M, Carracedo ÁM, Brion M. Genetic susceptibility in pharmacodynamic and pharmacokinetic pathways underlying drug-induced arrhythmia and sudden unexplained deaths [Internet]. Forensic Science International. 2019 ; 42 203-212.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.fsigen.2019.07.010
Trabalho de evento-resumo
Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de Varfarina (2019)
Gaspar, Claudia Manoel; Mendonça, C. E. A. F; Bastos, Gisele Medeiros ; Araújo, N. N. F; Hirata, Mario Hiroyuki
Source: Resumos. Conference titles: Simpósio Internacional de Iniciação Científica e Tecnológica da Universidade de São Paulo/SIICUSP. Unidade: FCF
Subjects: FARMACOGENÉTICA, ANTICOAGULANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GASPAR, Claudia Manoel et al. Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de Varfarina. 2019, Anais.. São Paulo: Pró-Reitoria de Pesquisa/USP, 2019. Disponível em: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210. Acesso em: 01 nov. 2024.
APA
Gaspar, C. M., Mendonça, C. E. A. F., Bastos, G. M., Araújo, N. N. F., & Hirata, M. H. (2019). Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de Varfarina. In Resumos. São Paulo: Pró-Reitoria de Pesquisa/USP. Recuperado de https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
NLM
Gaspar CM, Mendonça CEAF, Bastos GM, Araújo NNF, Hirata MH. Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de Varfarina [Internet]. Resumos. 2019 ;[citado 2024 nov. 01 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
Vancouver
Gaspar CM, Mendonça CEAF, Bastos GM, Araújo NNF, Hirata MH. Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de Varfarina [Internet]. Resumos. 2019 ;[citado 2024 nov. 01 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
Artigo de periodico
Inhibiting adenosine receptor signaling promotes accumulation of effector CD4+ T cells in the lung parenchyma during severe tuberculosis (2019)
Amaral, Eduardo Pinheiro ; Salles, Érika Machado de ; Bomfim, Caio César Barbosa ; Salgado, Rafael Moysés; Almeida, Fabricio Moreira; Souza, Paula Carolina de; Alvarez, José Maria ; Hirata, Mario Hiroyuki ; Lasunskaia, Elena B ; Lima, Maria Regina D'Império
Source: Journal of Infectious Diseases. Unidades: ICB, FCF
Subjects: ADENOSINA, CAFEÍNA, TUBERCULOSE, MYCOBACTERIUM TUBERCULOSIS, CAMUNDONGOS, PULMÃO, INTERFERONS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARAL, Eduardo Pinheiro et al. Inhibiting adenosine receptor signaling promotes accumulation of effector CD4+ T cells in the lung parenchyma during severe tuberculosis. Journal of Infectious Diseases, v. 219, n. 6, p. 964-974, 2019Tradução . . Disponível em: https://doi.org/10.1093/infdis/jiy586. Acesso em: 01 nov. 2024.
APA
Amaral, E. P., Salles, É. M. de, Bomfim, C. C. B., Salgado, R. M., Almeida, F. M., Souza, P. C. de, et al. (2019). Inhibiting adenosine receptor signaling promotes accumulation of effector CD4+ T cells in the lung parenchyma during severe tuberculosis. Journal of Infectious Diseases, 219( 6), 964-974. doi:10.1093/infdis/jiy586
NLM
Amaral EP, Salles ÉM de, Bomfim CCB, Salgado RM, Almeida FM, Souza PC de, Alvarez JM, Hirata MH, Lasunskaia EB, Lima MRD'I. Inhibiting adenosine receptor signaling promotes accumulation of effector CD4+ T cells in the lung parenchyma during severe tuberculosis [Internet]. Journal of Infectious Diseases. 2019 ; 219( 6): 964-974.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1093/infdis/jiy586
Vancouver
Amaral EP, Salles ÉM de, Bomfim CCB, Salgado RM, Almeida FM, Souza PC de, Alvarez JM, Hirata MH, Lasunskaia EB, Lima MRD'I. Inhibiting adenosine receptor signaling promotes accumulation of effector CD4+ T cells in the lung parenchyma during severe tuberculosis [Internet]. Journal of Infectious Diseases. 2019 ; 219( 6): 964-974.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1093/infdis/jiy586
Artigo de periodico
Molecular characterization of Mycobacterium tuberculosis and Mycobacterium bovis isolates by Enterobacterial Repetitive Intergenic Consensus-PCR (2018)
Ferracioli, Katiany Rizzieri Caleffi; Baldin, Vanessa Pietrowski; Noguti, Erika Noda; Siqueira, Vera Lúcia Dias; Scodro, Regiane Bertin Lima; Pavan, Fernando Rogerio; Hirata, Mario Hiroyuki ; Cardoso, Rosilene Fressatti
Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: TUBERCULOSE, MYCOBACTERIUM TUBERCULOSIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRACIOLI, Katiany Rizzieri Caleffi et al. Molecular characterization of Mycobacterium tuberculosis and Mycobacterium bovis isolates by Enterobacterial Repetitive Intergenic Consensus-PCR. Brazilian Journal of Pharmaceutical Sciences, v. 54, n. 3, p. 1-7 art. e17554, 2018Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902018000317554. Acesso em: 01 nov. 2024.
APA
Ferracioli, K. R. C., Baldin, V. P., Noguti, E. N., Siqueira, V. L. D., Scodro, R. B. L., Pavan, F. R., et al. (2018). Molecular characterization of Mycobacterium tuberculosis and Mycobacterium bovis isolates by Enterobacterial Repetitive Intergenic Consensus-PCR. Brazilian Journal of Pharmaceutical Sciences, 54( 3), 1-7 art. e17554. doi:10.1590/s2175-97902018000317554
NLM
Ferracioli KRC, Baldin VP, Noguti EN, Siqueira VLD, Scodro RBL, Pavan FR, Hirata MH, Cardoso RF. Molecular characterization of Mycobacterium tuberculosis and Mycobacterium bovis isolates by Enterobacterial Repetitive Intergenic Consensus-PCR [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54( 3): 1-7 art. e17554.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1590/s2175-97902018000317554
Vancouver
Ferracioli KRC, Baldin VP, Noguti EN, Siqueira VLD, Scodro RBL, Pavan FR, Hirata MH, Cardoso RF. Molecular characterization of Mycobacterium tuberculosis and Mycobacterium bovis isolates by Enterobacterial Repetitive Intergenic Consensus-PCR [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54( 3): 1-7 art. e17554.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1590/s2175-97902018000317554
Artigo de periodico
Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations (2018)
Hirata, Rosario Dominguez Crespo ; Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Hirata, Mario Hiroyuki
Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: DOENÇAS METABÓLICAS, POLIMORFISMO, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Rosario Dominguez Crespo et al. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations. Brazilian Journal of Pharmaceutical Sciences, v. 54, p. 1-25 art. e01005, 2018Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902018000001005. Acesso em: 01 nov. 2024.
APA
Hirata, R. D. C., Cerda, A., Genvigir, F. D. V., & Hirata, M. H. (2018). Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations. Brazilian Journal of Pharmaceutical Sciences, 54, 1-25 art. e01005. doi:10.1590/s2175-97902018000001005
NLM
Hirata RDC, Cerda A, Genvigir FDV, Hirata MH. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 1-25 art. e01005.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1590/s2175-97902018000001005
Vancouver
Hirata RDC, Cerda A, Genvigir FDV, Hirata MH. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 1-25 art. e01005.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1590/s2175-97902018000001005
Artigo de periodico
Application of aqueous two-phase micellar system to improve extraction of adenoviral particles from cell lysate (2018)
Molino, João Vitor Dutra; Lopes, André Moreni; Marques, Daniela de Araújo Viana; Mazzola, Priscila Gava; Silva, Joás Lucas da; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Gatti, Maria Silvia Viccari; Pessoa Junior, Adalberto
Source: Biotechnology and Applied Biochemistry. Unidade: FCF
Subjects: ADENOVÍRUS, CLARIFICAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOLINO, João Vitor Dutra et al. Application of aqueous two-phase micellar system to improve extraction of adenoviral particles from cell lysate. Biotechnology and Applied Biochemistry, v. 65, n. 3, p. 381-389, 2018Tradução . . Disponível em: https://doi.org/10.1002/bab.1627. Acesso em: 01 nov. 2024.
APA
Molino, J. V. D., Lopes, A. M., Marques, D. de A. V., Mazzola, P. G., Silva, J. L. da, Hirata, M. H., et al. (2018). Application of aqueous two-phase micellar system to improve extraction of adenoviral particles from cell lysate. Biotechnology and Applied Biochemistry, 65( 3), 381-389. doi:10.1002/bab.1627
NLM
Molino JVD, Lopes AM, Marques D de AV, Mazzola PG, Silva JL da, Hirata MH, Hirata RDC, Gatti MSV, Pessoa Junior A. Application of aqueous two-phase micellar system to improve extraction of adenoviral particles from cell lysate [Internet]. Biotechnology and Applied Biochemistry. 2018 ; 65( 3): 381-389.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/bab.1627
Vancouver
Molino JVD, Lopes AM, Marques D de AV, Mazzola PG, Silva JL da, Hirata MH, Hirata RDC, Gatti MSV, Pessoa Junior A. Application of aqueous two-phase micellar system to improve extraction of adenoviral particles from cell lysate [Internet]. Biotechnology and Applied Biochemistry. 2018 ; 65( 3): 381-389.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/bab.1627
Artigo de periodico
The low-density lipoprotein receptor-related protein 5 (LRP5) 4037C>T polymorphism: candidate for susceptibility to type 1 diabetes mellitus (2018)
Souza, Karla Simone Costa de; Ururahy, Marcela Abbott Galvão; Oliveira, Yonara Monique da Costa; Loureiro, Melina Bezerra; Silva, Heglayne Pereira Vital da; Bortolin, Raul Hernandes; Luchessi, André Ducati; Arrais, Ricardo Fernando; Hirata, Rosario Dominguez Crespo ; Almeida, Maria das Gracas; Hirata, Mario Hiroyuki ; Rezende, Adriana Augusto de
Source: Archives of Endocrinology Metabolism. Unidade: FCF
Subjects: POLIMORFISMO, LIPOPROTEÍNAS, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Karla Simone Costa de et al. The low-density lipoprotein receptor-related protein 5 (LRP5) 4037C>T polymorphism: candidate for susceptibility to type 1 diabetes mellitus. Archives of Endocrinology Metabolism, v. 62, n. 4, p. 480-484, 2018Tradução . . Disponível em: https://doi.org/10.20945/2359-399700000005. Acesso em: 01 nov. 2024.
APA
Souza, K. S. C. de, Ururahy, M. A. G., Oliveira, Y. M. da C., Loureiro, M. B., Silva, H. P. V. da, Bortolin, R. H., et al. (2018). The low-density lipoprotein receptor-related protein 5 (LRP5) 4037C>T polymorphism: candidate for susceptibility to type 1 diabetes mellitus. Archives of Endocrinology Metabolism, 62( 4), 480-484. doi:10.20945/2359-399700000005
NLM
Souza KSC de, Ururahy MAG, Oliveira YM da C, Loureiro MB, Silva HPV da, Bortolin RH, Luchessi AD, Arrais RF, Hirata RDC, Almeida M das G, Hirata MH, Rezende AA de. The low-density lipoprotein receptor-related protein 5 (LRP5) 4037C>T polymorphism: candidate for susceptibility to type 1 diabetes mellitus [Internet]. Archives of Endocrinology Metabolism. 2018 ; 62( 4): 480-484.[citado 2024 nov. 01 ] Available from: https://doi.org/10.20945/2359-399700000005
Vancouver
Souza KSC de, Ururahy MAG, Oliveira YM da C, Loureiro MB, Silva HPV da, Bortolin RH, Luchessi AD, Arrais RF, Hirata RDC, Almeida M das G, Hirata MH, Rezende AA de. The low-density lipoprotein receptor-related protein 5 (LRP5) 4037C>T polymorphism: candidate for susceptibility to type 1 diabetes mellitus [Internet]. Archives of Endocrinology Metabolism. 2018 ; 62( 4): 480-484.[citado 2024 nov. 01 ] Available from: https://doi.org/10.20945/2359-399700000005

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration